|
|
|
|
|
01.04.26 - 04:42
|
Base Carbon Reports Year End 2025 Operating and Financial Results (GlobeNewswire EN)
|
|
|
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC”, together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce its year-end 2025 consolidated financial results and operational highlights. All financial references are denominated in U.S. dollars, unless otherwise noted....
|
|
|
01.04.26 - 03:15
|
Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2025 (GlobeNewswire EN)
|
|
|
TEL AVIV, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today reported its unaudited consolidated financial results for the fourth quarter and year ended December 31, 2025....
|
|
|
|
|
01.04.26 - 02:03
|
FibroBiologics Announces Pricing of $3 Million Public Offering (GlobeNewswire EN)
|
|
|
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the pricing of a best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,272,728 shares of common stock (the “Warrants”), at a combined public offering price of $1.32 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $1.32 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Warrants (the “Stockholder Approval”) and will expire on the five-year anniversary of the date of Sto...
|
|
|
|
|
|
|
|
|
|
|
01.04.26 - 01:12
|
Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from “Algernon Health Inc.” to “Grey Matters Health Inc.” (the “Name Change”). The Company has reserved the new name and new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new symbols for the OTCQB and Frankfurt exchange will be provided shortly....
|
|
|
01.04.26 - 01:09
|
Prairie Provident Resources Announces Fourth Quarter and Year-End 2025 Financial and Operating Results and 2025 Year End Reserves (GlobeNewswire EN)
|
|
|
CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the fourth quarter and year ended December 31, 2025, along with its year-end reserves. Prairie Provident's audited annual consolidated financial statements and related Management's Discussion and Analysis ("MD&A") for the year ended December 31, 2025, and Annual Information Form dated March 31, 2026 containing year-end reserves data and other information for the period, are available on the Company's website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.03.26 - 23:42
|
Cloudastructure Inc. Reschedules Fourth Quarter 2025 Financial Results and Business Update Conference Call (GlobeNewswire EN)
|
|
|
PALO ALTO, CA, March 31, 2026 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) an award-winning leader in AI Surveillance and Remote Guarding, today announced that its previously scheduled conference call to discuss fourth quarter 2025 financial results and provide a business update has been rescheduled to Wednesday, April 1, 2026, at 12:00 PM Eastern Time....
|
|
|
|